Scripps Neurologist Weighs in on Parkinson's Psychosis Drug

Physician discusses FDA-approved drug with U-T

Caregiver holds hand of elderly man with Parkinson's disease.

Physician discusses FDA-approved drug with U-T

Melissa Houser, MD, founder and clinical director of the Parkinson's Disease and Movement Disorder Center at Scripps Clinic, discussed the benefits and safety risks of an FDA-approved drug used to treat psychosis in Parkinson's disease patients during a recent interview with The San Diego Union-Tribune.


Read the story in The San Diego Union-Tribune: Acadia's Parkinson's drug risk adequately disclosed, says FDA.

Media Contact

Keith Darce
858-678-7121
darce.keith@scrippshealth.org
Follow me: @KeithDarce